from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3873/PPE68

LFCtreatmentdescriptionclass of inhibitor

0.830

Amikacinug/mL Amikacintranslation

1.173

Cap5-10ug/mL Capreomycintranslation

3.335

Rox10-50 ug/mL Roxithromycintranslation

0.954

SM2-5 ug/mL Streptomycintranslation

1.148

Tet5-10 ug/mL Tetracyclinetranslation

-1.702

Rif0.2-5ug/mL Rifampicintranscription

-0.164

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.022

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.557

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.242

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.433

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.540

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.950

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.782

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.204

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.264

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.029

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.427

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.290

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.448

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.436

KCN5-20 ug/mL Potassium cyaniderespiration

-0.684

NaN30.2-2 mM Sodium aziderespiration

0.390

Nigericin50 uM Nigericinrespiration

-0.440

TRC10-150 ug/mL Triclosanrespiration

0.812

TRZ10-25 ug/mL Thioridazinerespiration

3.206

Valinomycin0.5-10 uM Valinomycinrespiration

-0.608

ZnSO42 mM ZnSO4respiration

0.589

menadione6-10 ug/mL Menadionerespiration

-0.709

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.437

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.108

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.383

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.450

NRP_1Non-replicating persistence stage 1dosRassociated

0.206

Amp0.2mg/mL AmpicillincellWall

-0.270

Cephalexin20-100 ug/mL CephalexincellWall

0.321

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.305

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.536

EMB10-20 ug/mL EthambutolcellWall

0.580

Eta12-40 ug/mL EthionamidecellWall

0.898

INH0.2-0.4 ug/mL IsoniazidcellWall

0.112

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.715

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.886

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.774

BZA0.12 mg/mL BenzamidearomaticAmides

0.467

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.809

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.133

H2O24 mM hydrogen peroxideDNAdamaging

-0.584

Levo10 ug/mL LevofloxacinDNAdamaging

-0.817

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.707

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.580

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.533

UVUV-irradiationDNAdamaging

0.003

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.702

Antimycin12.5-50 ug/mL Antimycin A?

-0.444

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.880

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.591

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.573

PA8240.2-2 ug/mL PA-824?

0.750

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.107

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.014

Verapamil50 uM Verapamil?

-0.250

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.389

methoxatin10-20 ug/mL Methoxatin?